EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Premedication in pediatric Meckel scintigraphy: pantoprazole versus ranitidine for optimizing scan quality

Hasan Önner, Merve Ni̇da Calderon Tobar, Mehmet Sarıkaya, Fatma Özcan Sıkı, Fari̇se Yılmaz, Muslu Kazim Körez, Gonca Kara Gedi̇k

Pediatric Radiology · 2025

DOI: 10.1007/s00247-025-06284-5 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pediatric Radiology, 2025. Verfasst von Hasan Önner und 6 weiteren Autor:innen. Beteiligte Einrichtung: Selçuk University, Medical Faculty, Department of Nuclear Medicine, Konya, Türkiye. hasan.onner@selcuk.edu.tr. Hauptthemen laut MEDLINE: Pantoprazole, Ranitidine, Radionuclide Imaging, Premedication. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Selcuk University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The standard method for diagnosing Meckel diverticulum and identifying ectopic gastric mucosa is 99 m Tc-pertechnetate imaging. Premedication with H 2 receptor antagonists enhances the scan’s sensitivity by reducing the washout of 99 m Tc-pertechnetate activity from the intestinal lumen.

Objective

After the withdrawal of ranitidine, we compared the efficacy of the proton pump inhibitor pantoprazole as an alternative premedication agent for 99 m Tc-pertechnetate Meckel diverticulum imaging. Materials and methods This study assessed the scan quality of 141 children (aged 1 month to 204 months (median = 84 months)) who underwent Meckel scintigraphy over 10 years at a single institution. Before its withdrawal in December 2020, ranitidine was utilized for premedication, while pantoprazole was used thereafter. Therefore, patients were divided into two premedication groups: ranitidine ( n = 88) and pantoprazole ( n = 53). A high-quality scan was defined as having no 99 m Tc-pertechnetate activity in the duodenal and other intestinal lumens. The effectiveness of pantoprazole in reducing 99 m Tc-pertechnetate release in the duodenum and other intestinal lumens was compared to that of ranitidine. Differences in scan quality between the groups were analyzed using the two-proportion Z -test. In patients with positive scans, the lesion-to-background activity ratio of the Meckel diverticulum was measured and compared between the premedication groups.

Results

Premedication with pantoprazole resulted in 47.2% of scans showing no 99 m Tc-pertechnetate release, 37.7% with activity localized either in the duodenum or other intestine, and 15.1% exhibiting activity in both regions. In comparison, ranitidine resulted in 45.5% of scans with no 99 m Tc-pertechnetate release, 40.9% with activity localized either in the duodenum or other intestine, and 13.6% showing activity in both regions. P -values were not found to be significant in all comparisons. Twelve scans were positive; all patients had Meckel diverticulum confirmed at surgery. For positive scans, the lesion-to-background activity ratio for the Meckel diverticulum was similar between the ranitidine and pantoprazole groups.

Conclusion

This study demonstrates that pantoprazole is statistically non-inferior to ranitidine regarding scan quality and lesion-to-background activity ratios for Meckel diverticulum detection. Pantoprazole offers a reliable alternative for clinical protocols in the absence of ranitidine. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PantoprazoleRanitidineRadionuclide ImagingPremedicationMeckel DiverticulumProton Pump InhibitorsHumansMaleChildFemaleChild, PreschoolInfantSodium Pertechnetate Tc 99mAdolescentRetrospective StudiesRadiopharmaceuticalsInfant, NewbornHistamine H2 Antagonists

Stichwörter der Autor:innen

Ectopic gastric mucosaMeckel diverticulumPantoprazolePediatricRanitidineScintigraphy

Substanzen

PantoprazoleRanitidineSodium Pertechnetate Tc 99mProton Pump InhibitorsRadiopharmaceuticalsHistamine H2 Antagonists

Autor:innen und Institutionen

  • Selçuk University, Medical Faculty, Department of Nuclear Medicine, Konya, Türkiye. hasan.onner@selcuk.edu.tr.
  • Selçuk University, Medical Faculty, Department of Nuclear Medicine, Konya, Türkiye.
  • Selçuk University, Medical Faculty, Department of Pediatric Surgery, Konya, Türkiye.
  • Selçuk University, Medical Faculty, Department of Biostatistics, Konya, Türkiye.

Förderung

  • Selcuk University

Zitieren

APA

Önner, H., Calderon Tobar, M. N., Sarıkaya, M., Özcan Sıkı, F., Yılmaz, F., Körez, M. K., & Kara Gedi̇k, G. (2025). Premedication in pediatric Meckel scintigraphy: pantoprazole versus ranitidine for optimizing scan quality. Pediatric Radiology. https://doi.org/10.1007/s00247-025-06284-5

Vancouver

Önner H, Calderon Tobar MN, Sarıkaya M, Özcan Sıkı F, Yılmaz F, Körez MK, et al. Premedication in pediatric Meckel scintigraphy: pantoprazole versus ranitidine for optimizing scan quality. Pediatric Radiology. 2025. doi:10.1007/s00247-025-06284-5

BibTeX
@article{nner2025,
  author = {Önner, Hasan and Calderon Tobar, Merve Ni̇da and Sarıkaya, Mehmet and Özcan Sıkı, Fatma and Yılmaz, Fari̇se and Körez, Muslu Kazim and Kara Gedi̇k, Gonca},
  title = {Premedication in pediatric Meckel scintigraphy: pantoprazole versus ranitidine for optimizing scan quality},
  journal = {Pediatric Radiology},
  year = {2025},
  doi = {10.1007/s00247-025-06284-5}
}
Kostenlos starten →